| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ENANTA PHARMACEUTICALS INC | Chief Medical Officer | Common Stock | 18.8K | $239K | $12.73 | Aug 8, 2024 | Direct |
| ENANTA PHARMACEUTICALS INC | Chief Medical Officer | Stock Option (Right to Buy) | 80.6K | Jul 15, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| ENTA | ENANTA PHARMACEUTICALS INC | Jul 11, 2024 | 5 | -$142K | 4 | Jul 15, 2024 | Chief Medical Officer |
| ENTA | ENANTA PHARMACEUTICALS INC | Feb 12, 2024 | 2 | -$9.37K | 4 | Feb 14, 2024 | Chief Medical Officer |
| ENTA | ENANTA PHARMACEUTICALS INC | Dec 5, 2023 | 1 | -$5.14K | 4 | Dec 6, 2023 | Sr. VP & CMO |
| ENTA | ENANTA PHARMACEUTICALS INC | Nov 22, 2023 | 1 | $0 | 4 | Nov 22, 2023 | Sr. VP & CMO |
| ENTA | ENANTA PHARMACEUTICALS INC | Aug 8, 2023 | 2 | -$43.9K | 4 | Aug 9, 2024 | Chief Medical Officer |
| ENTA | ENANTA PHARMACEUTICALS INC | Nov 23, 2022 | 2 | $0 | 4 | Nov 28, 2022 | Chief Medical Officer |
| ENTA | ENANTA PHARMACEUTICALS INC | Aug 8, 2022 | 2 | $0 | 4 | Aug 11, 2022 | Chief Medical Officer |
| ENTA | ENANTA PHARMACEUTICALS INC | Aug 8, 2022 | 0 | $0 | 3 | Aug 11, 2022 | Chief Medical Officer |